[ET Net News Agency, 23 November 2022] ALI HEALTH (00241) fell 3.06% to HK$5.39.
It hits an intra-day low of HK$5.37, and an intra-day high of HK$5.63. The total shares
traded was 11.92 million, with a value of HK$65.4m. The active buy/sell ratio is 40:60,
with net selling turnover of HK$12.81m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$5.37m, with volume weighted average price of HK$5.495.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of
HK$6.13m, with volume weighted average price of HK$5.455. The stock has fallen a combined
8.33% over the past 3 consecutive trading days.
The Hang Seng Index now rose 55 points, or 0.32% to 17,479; the Hang Seng China
Enterprises Index now rose 32 points, or 0.54% to 5,933; the Hang Seng TECH Index now rose
23 points, or 0.66% to 3,538; with an overall turnover of HK$21.93b.
The SSE Composite Index now fell 2 points, or 0.1% to 3,085, with an overall turnover of
RMB102.71b.
The SZSE Component Index now fell 78 points, or 0.71% to 10,924, with an overall
turnover of RMB50.23b.
Basic Information
=================
---------------------------------
Nominal 5.390 % Chg -3.06%
High 5.630 Low 5.370
Shares Tr 11.92m Turnover 65.4m
10-D SMA 5.297 %H.V 97.287
20-D SMA 4.552 VWAP 5.484
50-D SMA 4.022 RSI14 63.549
---------------------------------
Status: Active buy/sell ratio is 40:60, with net selling turnover of HK$12.81m, falling a
combined 8.33% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 5.39 -3.06
TRAD CHI MED (00570) 3.68 -3.66
SINO BIOPHARM (01177) 4.23 -1.17
INNOVENT BIO (01801) 29.00 -1.69
JXR (01951) 4.90 -2.78
FOSUN PHARMA (02196) 24.25 -2.61
WUXI BIO (02269) 47.30 -3.47
CANSINOBIO (06185) 102.00 -7.27
JD HEALTH (06618) 61.90 -1.04
AKESO-B (09926) 32.25 -3.73
---------------------------------------------
(ed)